Safety and Efficacy of the XIENCE V Everolimus-Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice-Reference-Cited by-同舟云学术

Safety and Efficacy of the XIENCE V Everolimus-Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice

Published:2012-05 Issue:9 Volume:109 Page:1288-1294
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Waksman Ron,Barbash Israel M.,Dvir Danny,Torguson Rebecca,Ben-Dor Itsik,Maluenda Gabriel,Xue Zhenyi,Satler Lowell F.,Suddath William O.,Kent Kenneth M.,Pichard Augusto D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization;Morice;N Engl J Med,2002

2. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

3. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-iv trial;Stone;Circulation,2004

4. In-hospital complications and long-term outcomes of the paclitaxel drug-eluting stent in acute ST-elevation myocardial infarction: a real-world experience from a high-volume medical center;Shammas;Cardiovasc Revasc Med,2009

5. Stent thrombosis following drug-eluting stent implantation: a single-center experience;Vaknin-Assa;Cardiovasc Revasc Med,2007

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology in development of next generation of stent and related medical devices: Current and future aspects;WIREs Nanomedicine and Nanobiotechnology;2024-03

2. Impact of Stent Expansion Index on Stent Failure After Left Main Stenting;The American Journal of Cardiology;2023-10

3. Prognostic Impact of Target Lesion Revascularization on Long-Term Cardiac Mortality After Current-Generation Drug-Eluting Stent Implantation for Left Main Distal Bifurcation: the Milan and New-Tokyo (MITO) Registry;Cardiovascular Revascularization Medicine;2023-04

4. Commercial pure titanium – A potential candidate for cardiovascular stent;Materialwissenschaft und Werkstofftechnik;2022-12

5. The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry;Scandinavian Cardiovascular Journal;2022-07-07